Effect of somatostatin receptor 2 antagonism on glucagon counterregulation during a hyperinsulinaemic euglycaemic-hypoglycaemic glucose clamp in adult men and women with long-standing type 1 diabetes: a randomised crossover phase 1 study.

Saved in:
Bibliographic Details
Title: Effect of somatostatin receptor 2 antagonism on glucagon counterregulation during a hyperinsulinaemic euglycaemic-hypoglycaemic glucose clamp in adult men and women with long-standing type 1 diabetes: a randomised crossover phase 1 study.
Authors: Abitbol A; LMC Diabetes & Endocrinology, Toronto, ON, Canada.; Centricity Research, Toronto, ON, Canada., Riddell MC; LMC Diabetes & Endocrinology, Toronto, ON, Canada.; Muscle Health Research Centre, York University, Toronto, ON, Canada., Peers S; Zucara Therapeutics Inc., Toronto, ON, Canada., Simonson E; Zucara Therapeutics Inc., Vancouver, BC, Canada., Evans M; Institute of Metabolic Science and Department of Medicine, University of Cambridge, Cambridge, UK., Knop FK; Center for Clinical Metabolic Research, Copenhagen University Hospital - Herlev and Gentofte, Hellerup, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Liggins RT; Zucara Therapeutics Inc., Vancouver, BC, Canada. rliggins@zucara.ca.
Source: Diabetologia [Diabetologia] 2026 Aug; Vol. 69 (8), pp. 2143-2154. Date of Electronic Publication: 2026 May 21.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0428
DOI:10.1007/s00125-026-06748-9